Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide

NCT04406246 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Infection

Interventions

DRUG: Nitazoxanide 500Mg Oral Tablet

Sponsor

Materno-Perinatal Hospital of the State of Mexico

Collaborators

[object Object]